OSL
Price sensitive
TRIPP-FFX Clinical Trial Meets Co-Primary Endpoints
Oncosil Medical Ltd
No summary is available for this announcement — open the PDF to read it in full.
Sign in for more about this company, including guidance changes and other insights.
Sign in